EGFR and neoplasm: Previously, we reported that NANOG was a crucial transcription factor driving the multi-refractory phenotypes of tumor cells, such as stem-like, metastatic and anti-apoptotic properties and resistance to multi-modal therapies via autophagy-mediated hyperactivation of the EGFR-AKT pathway14.